- Home
- NWL vs DNLI Comparison
NWL vs DNLI Comparison
Compare NWL & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWL
- DNLI
- Stock Information
- Founded
- NWL 1903
- DNLI 2013
- Country
- NWL United States
- DNLI United States
- Employees
- NWL N/A
- DNLI N/A
- Industry
- NWL Plastic Products
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NWL Industrials
- DNLI Health Care
- Exchange
- NWL Nasdaq
- DNLI Nasdaq
- Market Cap
- NWL 2.4B
- DNLI 2.1B
- IPO Year
- NWL N/A
- DNLI 2017
- Fundamental
- Price
- NWL $5.12
- DNLI $14.29
- Analyst Decision
- NWL Buy
- DNLI Strong Buy
- Analyst Count
- NWL 8
- DNLI 15
- Target Price
- NWL $7.31
- DNLI $33.85
- AVG Volume (30 Days)
- NWL 7.8M
- DNLI 1.5M
- Earning Date
- NWL 08-01-2025
- DNLI 08-12-2025
- Dividend Yield
- NWL 5.47%
- DNLI N/A
- EPS Growth
- NWL N/A
- DNLI N/A
- EPS
- NWL N/A
- DNLI N/A
- Revenue
- NWL $7,397,000,000.00
- DNLI N/A
- Revenue This Year
- NWL N/A
- DNLI N/A
- Revenue Next Year
- NWL $1.53
- DNLI $323.34
- P/E Ratio
- NWL N/A
- DNLI N/A
- Revenue Growth
- NWL N/A
- DNLI N/A
- 52 Week Low
- NWL $4.22
- DNLI $10.57
- 52 Week High
- NWL $11.78
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- NWL 40.85
- DNLI 51.71
- Support Level
- NWL $4.58
- DNLI $13.25
- Resistance Level
- NWL $6.34
- DNLI $14.53
- Average True Range (ATR)
- NWL 0.28
- DNLI 0.68
- MACD
- NWL -0.12
- DNLI 0.01
- Stochastic Oscillator
- NWL 30.00
- DNLI 54.74
About NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.